127 related articles for article (PubMed ID: 38583745)
1. CircUGGT2 facilitates progression and cisplatin resistance of bladder cancer through nonhomologous end-joining pathway.
Lyu F; Huang S; Yan Z; He Q; Liu C; Cheng L; Cong Y; Chen K; Song Y; Xing Y
Cell Signal; 2024 Jul; 119():111164. PubMed ID: 38583745
[TBL] [Abstract][Full Text] [Related]
2. Reconstitution of Mycobacterium marinum Nonhomologous DNA End Joining Pathway in
Zhang WW; Wright DG; Harrison L; Matlashewski G
mSphere; 2022 Jun; 7(3):e0015622. PubMed ID: 35695492
[TBL] [Abstract][Full Text] [Related]
3. CircUGGT2 downregulation by METTL14-dependent m
Chen XY; Yang YL; Yu Y; Chen ZY; Fan HN; Zhang J; Zhu JS
Pharmacol Res; 2024 Jun; 204():107206. PubMed ID: 38729588
[TBL] [Abstract][Full Text] [Related]
4. An Intrinsically Disordered APLF Links Ku, DNA-PKcs, and XRCC4-DNA Ligase IV in an Extended Flexible Non-homologous End Joining Complex.
Hammel M; Yu Y; Radhakrishnan SK; Chokshi C; Tsai MS; Matsumoto Y; Kuzdovich M; Remesh SG; Fang S; Tomkinson AE; Lees-Miller SP; Tainer JA
J Biol Chem; 2016 Dec; 291(53):26987-27006. PubMed ID: 27875301
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of GP130 signaling sensitizes bladder cancer to cisplatin by impairing Ku70 DNA repair signaling and promoting apoptosis.
He S; Li G; Schätzlein AG; Humphrey PA; Weiss RM; Uchegbu IF; Martin DT
Cell Signal; 2021 May; 81():109931. PubMed ID: 33529758
[TBL] [Abstract][Full Text] [Related]
6. CircLIFR synergizes with MSH2 to attenuate chemoresistance via MutSα/ATM-p73 axis in bladder cancer.
Zhang H; Xiao X; Wei W; Huang C; Wang M; Wang L; He Y; Sun J; Jiang Y; Jiang G; Zhang X
Mol Cancer; 2021 Apr; 20(1):70. PubMed ID: 33874956
[TBL] [Abstract][Full Text] [Related]
7. Effects of extremely low frequency electromagnetic field and cisplatin on mRNA levels of some DNA repair genes.
Sanie-Jahromi F; Saadat I; Saadat M
Life Sci; 2016 Dec; 166():41-45. PubMed ID: 27721000
[TBL] [Abstract][Full Text] [Related]
8. Rewiring E2F1 with classical NHEJ via APLF suppression promotes bladder cancer invasiveness.
Richter C; Marquardt S; Li F; Spitschak A; Murr N; Edelhäuser BAH; Iliakis G; Pützer BM; Logotheti S
J Exp Clin Cancer Res; 2019 Jul; 38(1):292. PubMed ID: 31287003
[TBL] [Abstract][Full Text] [Related]
9. A new phosphorylated form of Ku70 identified in resistant leukemic cells confers fast but unfaithful DNA repair in cancer cell lines.
Bouley J; Saad L; Grall R; Schellenbauer A; Biard D; Paget V; Morel-Altmeyer S; Guipaud O; Chambon C; Salles B; Maloum K; Merle-Béral H; Chevillard S; Delic J
Oncotarget; 2015 Sep; 6(29):27980-8000. PubMed ID: 26337656
[TBL] [Abstract][Full Text] [Related]
10. LRIK interacts with the Ku70-Ku80 heterodimer enhancing the efficiency of NHEJ repair.
Wang D; Zhou Z; Wu E; Ouyang C; Wei G; Wang Y; He D; Cui Y; Zhang D; Chen X; Reed SH; Luo J; Chen R
Cell Death Differ; 2020 Dec; 27(12):3337-3353. PubMed ID: 32587379
[TBL] [Abstract][Full Text] [Related]
11. Nonhomologous end joining repair pathway molecules as predictive biomarkers for patients with oral squamous cell carcinoma.
Joshi JS; Vora HH; Ghosh NR; Tankshali RN; Jetly DH; Trivedi TI
J Cancer Res Ther; 2021; 17(4):1031-1038. PubMed ID: 34528560
[TBL] [Abstract][Full Text] [Related]
12. Synthetic lethality between murine DNA repair factors XLF and DNA-PKcs is rescued by inactivation of Ku70.
Xing M; Bjørås M; Daniel JA; Alt FW; Oksenych V
DNA Repair (Amst); 2017 Sep; 57():133-138. PubMed ID: 28759779
[TBL] [Abstract][Full Text] [Related]
13. EIF4A3-mediated biogenesis of circSTX6 promotes bladder cancer metastasis and cisplatin resistance.
Wei W; Liu K; Huang X; Tian S; Wang H; Zhang C; Ye J; Dong Y; An Z; Ma X; Wang B; Huang Y; Zhang X
J Exp Clin Cancer Res; 2024 Jan; 43(1):2. PubMed ID: 38163881
[TBL] [Abstract][Full Text] [Related]
14.
Wei W; Sun J; Zhang H; Xiao X; Huang C; Wang L; Zhong H; Jiang Y; Zhang X; Jiang G
Cancer Res; 2021 Dec; 81(24):6142-6156. PubMed ID: 34702726
[TBL] [Abstract][Full Text] [Related]
15. Ku70 suppresses alternative end joining in G1-arrested progenitor B cells.
Liang Z; Kumar V; Le Bouteiller M; Zurita J; Kenrick J; Lin SG; Lou J; Hu J; Ye AY; Boboila C; Alt FW; Frock RL
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34006647
[TBL] [Abstract][Full Text] [Related]
16. Genetic interaction between DNA repair factors PAXX, XLF, XRCC4 and DNA-PKcs in human cells.
Xing M; Oksenych V
FEBS Open Bio; 2019 Jul; 9(7):1315-1326. PubMed ID: 31141305
[TBL] [Abstract][Full Text] [Related]
17. Exonuclease 1 (Exo1) Participates in Mammalian Non-Homologous End Joining and Contributes to Drug Resistance in Ovarian Cancer.
He D; Li T; Sheng M; Yang B
Med Sci Monit; 2020 Mar; 26():e918751. PubMed ID: 32167078
[TBL] [Abstract][Full Text] [Related]
18. ELL2 regulates DNA non-homologous end joining (NHEJ) repair in prostate cancer cells.
Zang Y; Pascal LE; Zhou Y; Qiu X; Wei L; Ai J; Nelson JB; Zhong M; Xue B; Wang S; Yang D; Lan L; Shan Y; Wang Z
Cancer Lett; 2018 Feb; 415():198-207. PubMed ID: 29179998
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitylation of Ku80 by RNF126 Promotes Completion of Nonhomologous End Joining-Mediated DNA Repair.
Ishida N; Nakagawa T; Iemura SI; Yasui A; Shima H; Katoh Y; Nagasawa Y; Natsume T; Igarashi K; Nakayama K
Mol Cell Biol; 2017 Feb; 37(4):. PubMed ID: 27895153
[TBL] [Abstract][Full Text] [Related]
20. Deletion of individual Ku subunits in mice causes an NHEJ-independent phenotype potentially by altering apurinic/apyrimidinic site repair.
Choi YJ; Li H; Son MY; Wang XH; Fornsaglio JL; Sobol RW; Lee M; Vijg J; Imholz S; Dollé ME; van Steeg H; Reiling E; Hasty P
PLoS One; 2014; 9(1):e86358. PubMed ID: 24466051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
